PAPERZILLA
Crunching Academic Papers into Bite-sized Insights.
About
Sign Out
← Back to papers

Health SciencesMedicineGenetics

American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support
SHARE
Overview
Paper Summary
Conflicts of Interest
Identified Weaknesses
Rating Explanation
Good to know
Topic Hierarchy
File Information
Paper Summary
Paperzilla title
To Match or Not to Match: New Blood Transfusion Guidelines for Sickle Cell Disease
These guidelines recommend extended red cell antigen typing and prophylactic matching for Rh and K antigens for all transfused SCD patients. They also address the management of alloimmunization, hyperhemolysis, iron overload, and transfusion strategies in specific clinical scenarios such as acute chest syndrome and pregnancy.
Possible Conflicts of Interest
Four panelists disclosed receiving payments or other transfers of value from companies that could be affected by the guidelines, although this occurred after recommendations were finalized.
Identified Weaknesses
Low certainty of evidence
The guidelines are based mostly on observational studies with low certainty of evidence, making it difficult to draw definitive conclusions about the effectiveness of specific interventions.
Reliance on expert opinion
Several recommendations rely on expert opinion due to a lack of direct evidence, making them potentially subjective.
Lack of cost-effectiveness data
The guidelines acknowledge that cost-effectiveness data is lacking for most interventions, making it difficult to assess their value in relation to their cost.
Limited generalizability
The guidelines focus primarily on patients with HbSS/HbSβ0 thalassemia, limiting the generalizability of the recommendations to other SCD genotypes.
Heterogeneity of included studies
The studies included in the review had variable methodologies and patient populations, which made it difficult to compare results and draw firm conclusions.
Rating Explanation
These guidelines provide a comprehensive overview of transfusion support in SCD, addressing key clinical questions and providing specific recommendations for practice. Although many recommendations are conditional due to the limited availability of high-certainty evidence, the guidelines offer valuable guidance based on the best available data and expert consensus. The identification of research priorities is also helpful to guide future research in this area.
Good to know
This is our free standard analysis. Paperzilla Pro fact-checks every citation, researches author backgrounds and funding sources, and uses advanced AI reasoning for more thorough insights.
Explore Pro →
Topic Hierarchy
Field:
Medicine
Subfield:
Genetics
File Information
Original Title:
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support
File Name:
pmc6988392.pdf
[download]
File Size:
1.17 MB
Uploaded:
July 14, 2025 at 10:43 AM
Privacy:
🌐 Public
© 2025 Paperzilla. All rights reserved.

If you are not redirected automatically, click here.